December 20, 2022 December 20, 2022Categories From the Co-ChairsFrom the Co-Chairs, December 2022Reflections on NCI-MATCH and its successor trials; research results in leukemia and breast cancer; and grant renewal preparations
December 20, 2022 December 20, 2022Categories Active Clinical TrialsRe-Opened Trial: EA9152 for T-cell or B-cell Acute Lymphoblastic LeukemiaThis study is investigating the safety and efficacy of venetoclax, a BCL-2 inhibitor, in combination with vincristine sulfate in the relapsed or refractory ALL population
December 20, 2022 December 20, 2022Categories PeopleRemembering Jerome C. Landry, MD, MBAIn July, the field of radiation oncology lost an expert and pioneer
December 20, 2022 December 20, 2022Categories PeopleRemembering Edward G. Mansour, MDIn November, the field of breast cancer research lost a revolutionary
December 20, 2022 December 20, 2022Categories Special Topics36 Member Networks and Programs Receive Commendations in 2022 for Outstanding Research PerformanceIn an annual evaluation, 36 member networks and programs met rigorous standards established by ECOG-ACRIN to indicate exemplary cancer research
December 20, 2022 December 20, 2022Categories News in BriefNews in Brief, December 2022Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
October 13, 2022 October 13, 2022Categories From the Co-ChairsFrom the Co-Chairs, October 2022Research results in breast and kidney cancer; recognition of key colleagues; and a sneak peek of the Fall 2022 Group Meeting
August 16, 2022 August 16, 2022Categories From the Co-ChairsFrom the Co-Chairs, August 2022President Biden to appoint Dr. Monica Bertagnolli as NCI Director; NCI-MATCH trial data leads to FDA drug approval
August 16, 2022 August 16, 2022Categories Institution SpotlightsInstitution Spotlight: Penn State Cancer InstituteA Standing Main Member of ECOG-ACRIN since 2002
June 21, 2022 June 21, 2022Categories From the Co-ChairsFrom the Co-Chairs, June 2022Reflections on the spring conference season, including highlights from the Spring Group Meeting and ASCO's Annual Meeting
June 21, 2022 June 21, 2022Categories Active Clinical TrialsNow Enrolling: EA9213 for T-Cell Acute Lymphoblastic LeukemiaThis single-arm phase 2 study aims to rid patients of residual disease following initial treatment
June 21, 2022 June 21, 2022Categories News in BriefNews in Brief, June 2022Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more